ClinicalTrials.gov: First posted in the last 14 days

Condition: Stress, Psychological
Intervention: Behavioral: Stress guide
Sponsors: Seoul National University Hospital; KT Corporation
Completed - verified July 2017

Condition: Vitamin D Deficiency
Intervention:
Sponsor: Lichen Yang
Completed - verified July 2017

Condition: Traumatic Brain Injury
Interventions: Device: early skull repair; Device: late-stage skull repair
Sponsor: Taihe Hospital
Active, not recruiting - verified July 2017

Conditions: Postoperative Sorethroat; Postoperative Pain
Intervention: Procedure: surgical procedure
Sponsor: Seoul National University Hospital
Recruiting - verified July 2017

Condition: Pre Diabetes
Interventions: Other: Algorithm-based diet; Other: Mediterranean-style low-fat diet
Sponsor: Weizmann Institute of Science
Recruiting - verified July 2017

Condition: COPD Exacerbation
Intervention: Device: Extubation to NIV
Sponsor: Assiut University
Not yet recruiting - verified July 2017

Conditions: Scoliosis Idiopathic; Scoliosis; Juvenile
Intervention: Device: Ultrasound
Sponsors: Children's Research Institute; Kitware, Inc.; National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Not yet recruiting - verified July 2017

Conditions: Autistic Disorder; Autism Spectrum Disorder; Child Development Disorders, Pervasive; Neurodevelopmental Disorders; Mental Disorders; Asperger's Syndrome; Neurobehavioral Manifestations; Nervous System Diseases
Intervention: Device: SQUED™ series 28.1 home-use
Sponsors: American Federation of Medical Synergetics; Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS; Institute of Medical Synergetics, Department of Cognitive Neurology WOMS; Laboratory of Neurocomputational Active Media WOMS; SQUED, Inc., USA; Center of Synergetics, Universität Stuttgart, Germany; Ivan Franko National University of Lviv, Ukraine; Danylo Halytsky Lviv National Medical University; World Organization of Medical Synergetics; World Autism Center, American Federation of Medical Synergetics
Recruiting - verified July 2017

Condition: Dementia
Interventions: Drug: prazosin hydrochloride; Drug: placebo
Sponsor: VA Office of Research and Development
Recruiting - verified July 2017

Condition: Esophageal Cancer
Intervention: Drug: SHR-1210
Sponsors: Tianjin Medical University Cancer Institute and Hospital; Jiangsu HengRui Medicine Co., Ltd.
Recruiting - verified July 2017

Condition: Breast Cancer
Interventions: Drug: Pembrolizumab; Drug: Eribulin
Sponsor: MedSIR
Not yet recruiting - verified July 2017

Conditions: Spinal Anaesthesia; Bladder Tumor; Transurethral Resection
Intervention:
Sponsor: Medical University of Warsaw
Recruiting - verified July 2017

Condition: Depressive Disorder
Interventions: Behavioral: Interpersonal Psychotherapy for Depressed Adolescents; Drug: Selective Serotonin Reuptake Inhibitor; Other: Usual Care
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Not yet recruiting - verified July 2017

Condition: Diabetes
Intervention:
Sponsors: Portsmouth Hospitals NHS Trust; AstraZeneca
Recruiting - verified July 2017

Condition: Acute Myeloid Leukemia
Intervention: Biological: CD33/CD38/CD56/CD117/CD123-specific gene-engineered T cells
Sponsor: Shenzhen Geno-Immune Medical Institute
Recruiting - verified July 2017

Conditions: Postoperative Ileus; Rectal Cancer
Interventions: Procedure: Electroacupuncture; Procedure: Sham Acupuncture
Sponsor: Chinese University of Hong Kong
Recruiting - verified July 2017

Condition: Pelvic Organ Prolapse
Intervention: Procedure: sacrospinous ligament fixation
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Active, not recruiting - verified February 2017

Condition: Mild to Moderate Psoriasis
Interventions: Drug: Icotinib hydrochloride cream; Drug: Placebo cream
Sponsors: Betta Pharmaceuticals Co.,Ltd.; Tigermed Consulting Co., Ltd
Not yet recruiting - verified July 2017

Condition: Small for Gestational Age Infant
Interventions: Biological: Somatropin Injection low dose group; Biological: Somatropin Injection high dose group
Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Tongji Hospital; Beijing Children's Hospital; The First Affiliated Hospital with Nanjing Medical University; Shanghai Children's Hospital; The Children's Hospital of Zhejiang University School of Medicine
Completed - verified July 2017

Conditions: Vitreous Injury; Retinal Detachment; Age Related Macular Degeneration
Intervention: Other: Surgery
Sponsor: Tel Aviv Medical Center
Completed - verified July 2017

Latest Images